The launch edition of India Health exhibition, organised by Informa Markets in India, concluded successfully at Yashobhoomi in Dwarka, New Delhi. The event brought together over 4000 attendees, including industry stakeholders, spanning biomedical engineers, pathologists, radiologists, hospital consultants, medical device distributors, clinicians, procurement managers, R&D professionals, and regulatory representatives.
Geo-located from the prestigious Arab Health exhibition, India Health aimed to provide a global platform for advancing healthcare together, nurturing a transformative environment for learning, networking, and collaboration with cutting-edge innovations and strategies from industry experts.
The event’s inauguration was attended by industry luminaries such as Istvan Szabo, Ambassador of Hungary, New Delhi, H.E. Jagannath Sami, High Commissioner of the Republic of Fiji, Dr Girdhar Gyani, Director General of the Association of Healthcare Providers India; Siddhartha Bhattacharya, Secretary General of the Healthcare Federation of India – NATHEALTH; Abhinav Thakur, MD, Accurex Biomedical (ADMI Representative); Dr Rajiv Chhibber, Vice President, External Affairs, Sahajanand Medical Technologies & Jt Coordinator, Govt & Public Affairs, AiMeD; Peter Hall, President, Middle East, India, Turkiye and Africa, Informa Markets; Wouter Molman, Chief Commercial Officer, Middle East, India, Turkiye and Africa, Informa Markets; Yogesh Mudras, Managing Director of Informa Markets in India; Rahul Deshpande, Senior Group Director, Informa Markets in India.
Dr Chhibber said, “At India Health Expo, the transformative impact of technology on India’s healthcare landscape is prominently highlighted. India’s medical device industry, currently valued at $11 billion, is growing at a staggering CAGR of 18-20 per cent, underscoring its rapid expansion and global competitiveness. It is projected to reach $50 billion by 2030 and over $250 billion by 2047. This growth trajectory is driven by initiatives like the PLI scheme and Atma Nirbhar Bharat, which focus on innovation and global alliances to set new benchmarks in healthcare delivery. This collaborative effort aims to enhance affordability, accessibility, and quality healthcare across all tiers of society, from rural communities to metropolitan areas, significantly advancing the management of both communicable and non-communicable diseases.”
Istvan Szabo, said “Life Sciences is one of Hungary’s oldest economic sectors, known for nearly a century of invention and significant exports. Hungary also boasts 17 Nobel Prizes. Our Life Sciences sector, divided into biotechnology, pharmaceuticals, and medical devices, is a crucial part of our economy. With high innovation, one-third of Hungary’s manufacturing, research, and development expenditure is dedicated to this sector. Eight of the top ten life science companies have facilities in Hungary.
“At India Health exhibition, 4 Hungarian companies, specialising in diagnostics, oncotherapy, nuclear medicine, and incubator manufacturing, showcase their solutions for the Indian market. We aim to foster successful collaborations between Hungarian and Indian companies, contributing to both countries’ success stories,” he added.
Abhinav Thakur said “In Vitro diagnostics industry is an $80 billion global market, with India contributing $1.5 billion, making us the fourth largest in Asia after Japan, China, and South Korea. Remarkably, we are the fastest-growing market globally, expanding at 15-20 per cent year on year. Globally, our market share ranks in the top 20, and diagnostics is the fastest-growing segment of medical devices. 70 per cent of medical decisions are based on diagnostic reports, yet diagnostics constitute only 2 per cent of a patient’s bill. This stark contrast underscores the critical role of diagnostics in preventive medicine.
Innovations like Health ATM, which enable testing anywhere, anytime without a laboratory, are game changers, especially for rural India, where 60 per cent of the population resides. Events like India Health, bringing over 150 international exhibitors, are crucial for bridging this gap, fostering collaborations that enhance our ‘Make in India’ initiative, and making diagnostics more affordable,” he added.
Speaking on the launch of India Health, Yogesh Mudras, “With India positioned as the 4th largest medical device market globally, alongside significant advancements in telemedicine and AI applications, the sector is poised for remarkable expansion. Forecasts predict telemedicine to reach USD 5.4 billion by 2025, with AI growing at an impressive 45 per cent annually by 2024, driving substantial employment opportunities in the healthtech sector. These insights, showcased at India Health, underscore the dynamic evolution of India’s healthcare landscape. The exhibition serves as a pivotal platform, bringing together leading global and domestic brands, and fostering collaboration and innovation across diverse sectors.”
Emphasising on the growth of healthcare sector, Siddhartha Bhattacharya said, “Currently, the healthcare landscape in India is undergoing a pivotal transformation. The country’s policies are increasingly geared towards ‘Health for All’ and ‘Make in India,’ reflecting a substantial push to extend healthcare beyond traditional contexts. The government is keen on supporting start-ups and innovative solutions by making regulatory policies more accessible and efficient. Together, these efforts are shaping a dynamic model for the future of healthcare in India, fostering an environment of growth and innovation.”
Further adding to it Dr Girdhar Gyani said, “Healthcare is now a significant priority for the government. In 2017, a new health policy was introduced, and in 2018, Ayushman Bharat, the world’s largest welfare insurance scheme, was launched, covering 500 million people. Currently, India has around 1.5 beds per thousand population, but the aim is to reach 3 beds per thousand. This disparity in healthcare infrastructure across states presents a substantial investment opportunity. From 2014 to 2024, the number of MBBS seats has doubled from 50,000 to 100,000, indicating a growing influx of healthcare professionals. However, until the demand for postgraduate doctors, nurses, and paramedics is met, healthcare technology and information technology will drive the sector. India remains a vast and promising market for healthcare advancements.
Highlighting the crucial healthcare collaboration between India and Fiji, Jagannath Sami, stated “Most Pacific Island countries identify sicknesses late, so our focus is on diagnostics to prevent illnesses and improve health outcomes. India Health exhibition provides a valuable opportunity to explore these solutions. We are planning to enhance our health sector, including health centers and pharmacies, and we are committed to embracing diagnostics across the Pacific Islands. “
Peter Hall, concluded by saying, “It is a pleasure to announce the launch of the India Health Exhibition, a significant milestone for India’s healthcare industry. India Health is geo-adapted from Arab Health, one of the world’s largest healthcare events held in Dubai, which will celebrate its 50th anniversary in 2025. India has long been at the forefront of global healthcare, playing a significant role in pharmaceutical production and distribution. Projections indicate that India’s healthcare sector will exceed $638 billion by 2025, underscoring its pivotal position in the industry. India Health launch edition features global and domestic brands across various genres, symbolising a new era of collaboration, innovation, and progress.”